Skip to content

Screener

Eligibility screening

Ivosidenib, Venetoclax, and Azacitidine for Hematologic Malignancies

Sponsored by M.D. Anderson Cancer CenterStudy detailsClinicalTrials.gov

4 US sites in MA, OH, OR, TX

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.